David Nicholson

David Nicholson

Director/Board Member at ACTINIUM PHARMACEUTICALS, INC.

Net worth: 493 $ as of 2026-10-30

72 year
Health Technology
Commercial Services
Finance

Profile

David C.
Nicholson
is Chairman at Exscientia AI Ltd. since 2020.
He is Non-Executive Chairman at Wild Bioscience Ltd. starting in 2023.
He serves as Director at Rapalogix Health, Inc., Science Exchange, Inc. since 2018, Tarus Therapeutics, Inc. since 2020, and Volastra Therapeutics, Inc. He is Lead Independent Director at Actinium Pharmaceuticals, Inc. since 2017.
He is also an Operational Partner at Gilde Healthcare Partners, Inc. since 2020.
Former roles include Non-Executive Chairman at Exscientia Ltd. from 2023 to 2024, Independent Director at Adverum Biotechnologies, Inc. from 2023 to 2025, Director at Cactus Ventures, Inc. from 2012 to 2013, Vice President-Licensing & Knowledge Management at Merck & Co., Inc. from 2009 to 2011, SVP-Global Project Management & Drug Safety at Schering-Plough Corp.
USA from 2007 to 2009, Chief Technology Officer & Executive VP at Bayer CropScience AG from 2012 to 2014, Executive VP-Research & Development at Organon International, Inc. from 1988 to 2007, Executive VP-Research & Development at Organon Biosciences, Inc. in 2007, Executive VP, Chief Research & Development Officer at Allergan UC from 2015 to 2020, CTO, Head-Research & Development at Bayer Crop Science Solutions LLC from 2012 to 2014, Vice Chairman at Transcelerate Biopharma, Inc., Director at Actinium Pharmaceuticals, Inc., Senior Vice President at Forest Laboratories, Inc. Education includes an undergraduate degree from The University of Manchester in 1975 and a doctorate from The University of Wales in 1980.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-10-01 333 ( 0% ) 493 $ 2026-10-30

David Nicholson active positions

CompaniesPositionStart
ACTINIUM PHARMACEUTICALS, INC. Director/Board Member 2007-12-31
Chairman 2020-09-30
Chairman 2023-11-02
Director/Board Member 2018-06-27
Director/Board Member 2020-05-13
Director/Board Member -
Private Equity Investor 2020-08-31

Former positions of David Nicholson

CompaniesPositionEnd
ADVERUM BIOTECHNOLOGIES, INC. Director/Board Member 2025-12-08
EXSCIENTIA PLC Chairman 2024-02-11
░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░ ░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of David Nicholson's experience

Education of David Nicholson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

81

1st degree connections

22

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies22

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Consumer Services

Process Industries

Health Technology

Consumer Services

Organon Biosciences, Inc.

Health Technology

Technology Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Commercial Services

  1. Stock Market
  2. Insiders
  3. David Nicholson